Vimarsana
Biggest News Aggregation in the World

Page 2 - Hakim Bouterfa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hakim Bouterfa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hakim Bouterfa Today - Breaking & Trending Today

​​​​​​​Reorganization in the Executive Board of Eckert & Ziegler - Vimarsana News

​​​​​​​Reorganization in the Executive Board of Eckert & Ziegler

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word: Personnel ​​​​​​​Reorganization in the Executive Board of Eckert &... | May 15, 2023

Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm's Primary Aldosteronism Lead Candidate - Vimarsana News

Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm's Primary Aldosteronism Lead Candidate

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word: Alliance Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International... | May 8, 2023

Changes in the Management Board of Eckert & Ziegler - Vimarsana News

Changes in the Management Board of Eckert & Ziegler

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): PersonnelChanges in the Management Board of Eckert & Ziegler19-Dec-2022 / 13:29 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is...

EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial - Vimarsana News

EQS-News: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Study First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial 27.10.2022 / 10:59 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin/Aalborg, 27 October 2022. The Universit...

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial - Vimarsana News

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG: First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Study First CNS Lymphoma Patient Imaged with PentixaFor in Phase 2 Trial 27.10.2022 / 10:59 CET/CEST The